Tumor Shedding and Coagulation
- 22 May 1981
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 212 (4497) , 923-924
- https://doi.org/10.1126/science.7195067
Abstract
Three syngeneic carcinomas from two species shed plasma membrane vesicles when cultured in vitro or grown in the ascites tumor form in vivo. Shed vesicles carry procoagulant activity that can account for the activation of the clotting system and the fibrin deposition associated with these and many other types of malignancy in animals and man.This publication has 24 references indexed in Scilit:
- An association between actin and the major histocompatibility antigen H–2Nature, 1978
- TROUSSEAUʼS SYNDROME AND OTHER MANIFESTATIONS OF CHRONIC DISSEMINATED COAGULOPATHY IN PATIENTS WITH NEOPLASMSMedicine, 1977
- Cell surface shedding—The phenomenon and its possible significanceJournal of Theoretical Biology, 1976
- Thromboplastic activity of human ovarian tumoursThrombosis Research, 1975
- Association of tissue factor activity with the surface of cultured cells.Journal of Clinical Investigation, 1975
- Cancer procoagulant A: A factor X activating procoagulant from malignant tissueThrombosis Research, 1975
- Tumor AngiogenesisAdvances in Cancer Research, 1974
- Tumor fluid thromboplastin activityInternational Journal of Cancer, 1968
- Clot forming and clot stabilizing enzymes from the mouse tumor YPC-1Biochemical and Biophysical Research Communications, 1966
- The reaction of guinea‐pigs to autologous and heterologous fibrin implantsThe Journal of Pathology and Bacteriology, 1965